|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000882037 |
| 003 |
SK-MaSNL |
| 005 |
20260304215403.0 |
| 008 |
250505c2004 xo 0 slo |
| 015 |
|
|
|a SNBRB2004/08-24704
|
| 035 |
|
|
|a CLN000233534
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab6zbu
|
| 035 |
|
|
|a (uuid)203a64b0-0320-4ff3-af34-cb174d2ac601
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06cbx
|
| 035 |
|
|
|a (sysno)vtls000882037
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 575.113:616-006.6-085:82-95
|2 1997
|
| 100 |
1 |
|
|a Altaner, Čestmír,
|d 1933-
|4 aut
|9 23680
|
| 245 |
1 |
0 |
|a Suicide gene therapy
|b methods and reviews
|c C. Altaner
|
| 650 |
0 |
7 |
|a gény transgénové suicidálne
|x genetika
|2 MESH
|9 1550085
|
| 650 |
0 |
7 |
|a molekulárna biológia
|2 MESH
|9 68116
|
| 650 |
0 |
7 |
|a adjuvanciá imunologické
|x aplikácia a dávkovanie
|x analýza
|2 MESH
|9 1550086
|
| 650 |
0 |
7 |
|a profil vplyvu choroby na zdravotný stav
|2 MESH
|9 871285
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 773 |
0 |
|
|t Neoplasma
|g Vol. 51, no. 4 (2004), p. 235
|x 0028-2685
|
| 787 |
0 |
8 |
|i Rec.:
|a Springer, C.J.
|t Suicide gene therapy
|d Totowa, New Jersey : Humana Press, 2003
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 958 |
|
|
|a article27
|
| 958 |
|
|
|a RC
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 3146096
|d 3148026
|
